Des-γ-carboxyprothrombin (DCP), also known as “protein induced by vitamin K absence or antagonist-II” (PIVKA-II), is an abnormal prothrombin that has been widely used as a tumor marker for HCC, and could be predictive of worse tumor behavior and prognosis [2–5]. This evidence concerns the gene F2 and neoplasm.